Menu Search
Equities

Jiangxi Rimag Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
2522:HKG.HS

Jiangxi Rimag Group Co Ltd

Actions
  • Price (HKD)7.59
  • Today's Change0.06 / 0.80%
  • Shares traded362.50k
  • 1 Year change-80.69%
  • Beta--
Data delayed at least 15 minutes, as of Feb 16 2026 04:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Jiangxi Rimag Group Co Ltd is a China-based company that is primarily engaged in medical imaging specialty medical business. The Company mainly provides medical imaging services and solutions. The Company operates in three segments. Imaging Center Services provide imaging examination and diagnosis services to patients and other healthcare consumers through flagship imaging centers. Imaging Solution Services mainly help hospitals and other medical institution customers select and purchase appropriate imaging equipment to meet their development needs, and provide a series of supporting modular solutions. Rimag Cloud Services provide support for the development of imaging center service business, information management and data-driven operations.

  • Revenue in HKD (TTM)920.81m
  • Net income in HKD-37.69m
  • Incorporated2014
  • Employees1.36k
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.